Pharmaceutical Labeling. Managing Regulations and Requirements for Pharmaceutical Labeling
|
|
- Annice Cain
- 5 years ago
- Views:
Transcription
1 Pharmaceutical Labeling Managing Regulations and Requirements for Pharmaceutical Labeling
2 Table of Contents 1. Don't Understate Dangers of Counterfeit Pharmaceuticals 2. DSCSA is in effect, and supply chains must keep up 3. Need Help Implementing & Maintaining a Validated and Compliant Labeling Solution? 4. Make your Labeling Count
3 Don't Understate Dangers of Counterfeit Pharmaceuticals
4 Most of the time, when you buy a counterfeit consumer product, you'll be annoyed. The quality of the materials and the performance likely won't be up to the standards that you expect. You'll probably want your money back, and you might demand answers from the retailer that sold the product to you. But most counterfeit consumer products won't affect your health the way that counterfeit pharmaceutical drugs might. The makers of fake drugs aren't just depriving legitimate manufacturers of revenue they're also harming people. Mark Davison, Principal Consultant & CEO at Blue Sphere Health, recently told Pharmaceutica Processing that counterfeit drugs can be more of a problem than many assume. These aren't like generic medicines, which are legal, regulated and must be as effective as brand-name medications. Counterfeiters deliberately attempt to deceive consumers by passing off medications that, in some cases, can be significantly different from the original product. On top of that, they may not even be properly sterilized. Davison argues that many legitimate manufacturers have been slow to recognize the threat that counterfeiting poses to their product lines. "Don't assume that your products are immune," he told the news source. The U.S. Food and Drug Administration (FDA) has sought to stem the tide of counterfeiting through the use of the Drug Supply Chain Security Act (DSCSA),
5 which created a nationwide "track and trace" system when it was enacted in Drug manufacturers seeking to comply must label their products with unique serial numbers. It can be difficult for manufacturers to keep up with changing federal regulations, but preventing drug counterfeiting is worth the effort. Enterprise Labeling Solutions can help drug makers keep their labels in compliance on a large scale, with greater efficiency. To find out more about Pharmaceutical Labeling and meeting all of your regulatory challenges, check out our webinar on labeling best practices with customer, Ferring Pharmaceuticals.
6 DSCSA is in effect, and supply chains must keep up
7 Given the great risk if anything goes wrong, every element of the pharmaceutical supply chain must be held to extremely high standards. If your company is affected by the Food and Drug Administration's Drug Supply Chain Security Act, which is Title II of the Drug Quality and Security Act, failure to catch up with the relevant regulations may result in damaging fines and other legal action. Still Rolling Out One factor to keep in mind about the DSCSA is that it is not a one-and-done implementation. Its first few provisions came into effect in 2014 and 2015, but baked into the law is a roll-out process that will last through In that time, the FDA plans to work with businesses such as manufacturers, distributors, wholesalers, repackagers and dispensers to add more provisions. Unique product identification, tracing, and verification top the FDA's list of what's to come. Supply chain transparency at all levels is the endgame. The agency hopes that in the future, it will be easier to determine immediately whether drug products are real and counterfeit. Recalls will also become more precise and efficient. Current Provisions Since 2015, several elements of the DSCSA have been in effect. Product tracing at the lot level has been required since January 1, 2015, all in line with FDA standards. Since then, a trading partner authorization requirement has also applied. This means every part of the supply chain must have approval from
8 the appropriate bodies. Working with Labels Barcode labels and the related software are essential for companies making their products trackable up to FDA standards. As laws evolve over the next seven years, there will inevitably be more changes required of manufacturers, distributors and pharmacies. And if their labeling systems are flexible and comprehensive, they will respond to these rolling modifications with ease. For more on pharmaceutical labeling check our Pharmaceutical Labeling resources - "7 Ways to Stay Compliant, Stay Competitive with Enterprise Labeling."
9 Need Help Implementing & Maintaining a Validated and Compliant Labeling Solution? Look no further - Loftware offers a comprehensive enterprise solution that meets the needs of medical device and pharmaceutical manufacturers. Loftware recently announced that they have partnered with USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, to deliver the new Loftware Validation Accelerator Pack (VAP). The Loftware VAP enables customers to quickly and cost-effectively implement and maintain a validated and compliant labeling solution. This new solution which simplifies compliance, increases productivity and minimizes validation costs, complements Loftware Spectrum, the industry s most
10 powerful labeling solution designed to address the unique complexities and regulatory requirements of labeling in the pharmaceutical and medical device space. The Loftware VAP, which enables Loftware s medical device customers to validate Loftware Spectrum to meet FDA and EU regulatory requirements, provides a standardized approach for ongoing validation. The Loftware VAP paired with Loftware Spectrum s configurable workflow framework and esignature capabilities provides a jump-start towards validation and helps to facilitate 21 CFR Part 11, underscoring Loftware s ongoing commitment to medical device and pharmaceutical labeling. USDM s VAPs have proven to help companies meet the requirements of the FDA and other Regulatory Agency validation requirements for computer systems and equipment supporting regulated functions. The UDI Final Rule certainly resulted in medical device companies updating or implementing new systems and equipment that require validation, stated Jay Crowley, Vice President of UDI Services and Solutions at USDM Life Sciences. The Loftware Validation Accelerator Pack (VAP) helps these companies meet compliance requirements while reducing validation time and costs by up to 50%, achieving better efficiency and a competitive edge. Loftware and USDM developed the Loftware VAP to be comprehensive and include key components for validation and compliance in the medical device field. The package is a complete set of content rich validation templates that are ready to be configured to reflect each customer s configuration decisions. Our partnership with USDM is a perfect complement to Loftware Spectrum which provides unrivaled capabilities for meeting the complexities of labeling in highly regulated industries, stated Josh Roffman, Vice President Product Management at Loftware. With the Loftware VAP, we re able to further accelerate and streamline the validation process, providing an integrated and comprehensive labeling solution that simplifies compliance, increases productivity and minimizes validation costs, he added. For more on Pharmaceutical Labeling, check out our Q&A report on the topic.
11 Make your Labeling Count For more information how you can meet all of your Pharmaceutical Labeling needs, contact Loftware today. BOOK A CONSULTATION
II. The January 1, 2009 Implementation Deadline Should be Extended to January 1, 2011
1 I. Introduction Written Testimony of David Wilcox on behalf of the National Community Pharmacists Association before the Enforcement Committee of the California Board of Pharmacy Hearing on E-pedigree
More informationDSCSA and Blockchain Study
DSCSA and Blockchain Study Exploring the use of blockchain technology within Healthcare 9/30/2016 The Purpose of this Study There has been much discussion regarding the use of blockchain technology within
More informationGrandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier
Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.
More informationANNEX 1 STRATEGIES BY NRRA TO DETECT ACTIONS, ACTIVITIES AND BEHAVIOURS THAT RESULT IN SSFFC MEDICAL PRODUCTS
ANNEX 1 RECOMMENDATIONS FOR HEALTH AUTHORITIES TO DETECT AND DEAL WITH ACTIONS, ACTIVITIES AND BEHAVIOURS THAT RESULT IN SUBSTANDARD/SPURIOUS/FALSELY-LABELLED/ FALSIFIED/COUNTERFEIT MEDICAL PRODUCTS I.
More informationState of Blockchain Adoption on the Pharmaceutical Supply Chain Industry Study
State of Blockchain Adoption on the Pharmaceutical Supply Chain Industry Study Executive Summary October 2017 The Industry Challenge Pharmaceutical manufacturers, in collaboration with their trusted partners,
More informationMoving from Pediatric to Adult Care: Prescription Medicines, Supplies, and Equipment
Moving from Pediatric to Adult Care: Prescription Medicines, Supplies, and Equipment To take care of your own health, you need to know how to fill prescriptions. Most prescriptions for medicines can be
More informationWhat you need to know about credit card processing? The basics of credit card processing? A diagram showing the flow of data authorization
1 2 What you need to know about credit card processing? The basics of credit card processing? A diagram showing the flow of data authorization 3 4 5 Understanding processing fees - Dues & assessments -
More informationEU Falsified Medicines Directive developments and implementations across Europe
EU Falsified Medicines Directive developments and implementations across Europe June 2016 Joan Cahill Pfizer EFPIA Supply Chain Workgroup Coding & Serialisation Disclaimer This presentation does not necessarily
More informationWholesale Importation Program for Prescription Drugs Legislative Report
Report to The Vermont Legislature Wholesale Importation Program for Prescription Drugs Legislative Report In Accordance with Act 133. Sec.1 An Act Relating to the Wholesale Importation of Prescription
More informationValuation Public Comps and Precedent Transactions: Historical Metrics and Multiples for Public Comps
Valuation Public Comps and Precedent Transactions: Historical Metrics and Multiples for Public Comps Welcome to our next lesson in this set of tutorials on comparable public companies and precedent transactions.
More informationPurchase Price Allocation, Goodwill and Other Intangibles Creation & Asset Write-ups
Purchase Price Allocation, Goodwill and Other Intangibles Creation & Asset Write-ups In this lesson we're going to move into the next stage of our merger model, which is looking at the purchase price allocation
More informationA8-0148/ AMENDMENTS by the Committee on the Internal Market and Consumer Protection
13.1.2016 A8-0148/ 001-157 AMDMTS 001-157 by the Committee on the Internal Market and Consumer Protection Report Vicky Ford Personal protective equipment A8-0148/2015 (COM(2014)0186 C7-0110/2014 2014/0108(COD))
More informationECO LECTURE TWENTY-FOUR 1 OKAY. WELL, WE WANT TO CONTINUE OUR DISCUSSION THAT WE HAD
ECO 155 750 LECTURE TWENTY-FOUR 1 OKAY. WELL, WE WANT TO CONTINUE OUR DISCUSSION THAT WE HAD STARTED LAST TIME. WE SHOULD FINISH THAT UP TODAY. WE WANT TO TALK ABOUT THE ECONOMY'S LONG-RUN EQUILIBRIUM
More informationPharmaceutical Trademarks
Published by Pharmaceutical Trademarks 2012 United States Contributing firm Third Edition United States Contributing firm Authors Nick de la Torre and Jennifer Theis Selection, clearance and registration
More informationQ Formulary Performance:
Insights Executive Briefing Issue 10, 2016 Q1 2016 Performance: Key Data to Consider as You Look Ahead to 2017 Increasingly our clients see proactive, dynamic formulary management as a necessary response
More informationAlabama State Board of Pharmacy New Manufacturer Application
Alabama State Board of Pharmacy New Manufacturer Application Date Received Manufacturer: A person or entity, except a pharmacy, who prepares, derives, produces, researches, test, labels, or packages any
More informationCase M TEVA/ALLERGAN GENERICS
EUROPEAN COMMISSION DG Competition Case M. 7746 TEVA/ALLERGAN GENERICS Only the English text is available and authentic. REGULATION (EC) No 139/2004 MERGER PROCEDURE Decision on the implementation of remedies
More informationMANUFACTURING AND DISTRIBUTION
MANUFACTURING AND DISTRIBUTION WHAT OUR CLIENTS SAY Our relationship goes way beyond transactional, they give me unique and valuable insights about the community and the service is very high quality. I
More informationUnderstanding your Pharmacy Benefit
Understanding your Pharmacy Benefit At UnitedHealthcare, we want to help you get the most out of your pharmacy benefit. Here, you'll find answers to some frequently asked questions, because we re dedicated
More informationForex Illusions - 6 Illusions You Need to See Through to Win
Forex Illusions - 6 Illusions You Need to See Through to Win See the Reality & Forex Trading Success can Be Yours! The myth of Forex trading is one which the public believes and they lose and its a whopping
More informationPENNSYLVANIA COMPENSATION RATING BUREAU. Evaluation of House Bill 1846 of 2014 (HB1846)
Exhibit 34 As Filed Evaluation of House Bill 1846 of 2014 (HB1846) The PCRB previously evaluated HB1846 for the purpose of PCRB Proposals C-365, C-366 and C-368, the Pennsylvania loss cost filings effective
More informationGilead Transparency Reporting Methodological Note
Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers
More information1. INTRODUCTION. Activity A of the WHO Member State Mechanism November 2017
RECOMMENDATIONS FOR HEALTH AUTHORITIES ON CRITERIA FOR RISK ASSESSMENT AND PRIORITIZATION OF CASES OF UNREGISTERED/UNLICENSED, SUBSTANDARD AND FALSIFIED MEDICAL PRODUCTS 1. INTRODUCTION Activity A of the
More informationYour guide to understanding your Small Group renewal packet. Table of contents
Your guide to understanding your Small Group renewal packet Table of contents 38844OHEENABS 11/13 How can this guide help me? What s in my renewal packet? What s changing because of the ACA? The essentials
More informationEFPIA Position Paper (25/05/10)
Consultation Paper from DG for Taxation and Customs Union (Unit Taxud/C3) Review of EU legislation on customs enforcement of intellectual property rights EFPIA Position Paper (25/05/10) Introduction EFPIA
More information(recast) (Text with EEA relevance)
29.3.2014 Official Journal of the European Union L 96/107 DIRECTIVE 2014/31/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 26 February 2014 on the harmonisation of the laws of the Member States relating
More informationCash Flow Statement [1:00]
Cash Flow Statement In this lesson, we're going to go through the last major financial statement, the cash flow statement for a company and then compare that once again to a personal cash flow statement
More informationNewgen Solution for FATCA compliance. Built-on Dynamic Rules Driven BPM Suite
Newgen Solution for FATCA compliance Built-on Dynamic Rules Driven BPM Suite FATCA Foreign Account Tax Compliance Act. Overview The Foreign Account Tax Compliance Act (FATCA) was enacted by the United
More informationBenefits Module Release Notes
Release Notes for 03/12/19 Modifying an Existing Quality of Life Event The functionality for an employee to modify an existing Qualifying Life Event (QLE) or choose to begin a new QLE will be released
More informationEU VAT Forum. Consolidated report on Cooperation between Member States and Businesses in the field of e-commerce/modern commerce
EUROPEAN COMMISSION DIRECTORATE-GENERAL TAXATION AND CUSTOMS UNION Indirect Taxation and Tax administration Tax administration and fight against tax fraud taxud.c.4(2018) 1507602 12.03.2018 EU VAT Forum
More information2017 Global BEPS Survey Report
1 November 2017 2 Executive Summary Respondent Breakout BEPS comes into focus For the third consecutive year, Thomson Reuters sought to determine corporations compliance with the OECD s BEPS recommendations.
More informationGetting ready for the GST changes
Getting ready for the GST changes On 1 October 2010, the GST rate is going up to 15 per cent along with other changes such as updated PAYE rates. While the changes might seem fairly simple, they're part
More informationAccess to Medicines in Low and Middle Income Countries: Goals and Challenges. Andreas Seiter The World Bank August 2013
Access to Medicines in Low and Middle Income Countries: Goals and Challenges Andreas Seiter The World Bank August 2013 1 The World Bank and its clients Financing (IDA, subsidized) Low-Income Countries
More informationQ2. Where can consumers and small businesses purchase BlueSimplicity plans?
Learn More Frequently Asked Questions 2017 BlueSimplicity SM Member Q&A BlueSimplicity Plans o Plan basics and availability o Access to care o Benefit design BlueSimplicity Plans Plan basics and availability
More informationMARGIN MONEY To enter into these futures contract you need not put in the entire money. For example, reliance shares trades at Rs 1000 in the share
MARGIN MONEY To enter into these futures contract you need not put in the entire money. For example, reliance shares trades at Rs 1000 in the share market. If you want to enter into one lot of Reliance
More informationThe Connected Disciplines of Risk Disclosure and Risk Management
The Connected Disciplines of Risk Disclosure and Risk Management Today s Presenter Mike Rost Vice President of Vertical Solution Strategy Workiva Agenda Introduction Risk disclosure current state and trends
More informationEGP 2.9 BN 51.1% y-o-y. EGP 216 MN 44.9% y-o-y. EGP 92 MN 69.4% y-o-y. EGP 28 MN 46.3% y-o-y. EGP 36 MN 88.4% y-o-y.
EARNINGS RELEASE Ibnsina Pharma Releases Audited Results Ibnsina Pharma starts 2018 off strong with year-on-year revenue and EBITDA growth of 51% and 69% respectively in 1Q2018, ensuring a sustained growth
More informationCan a 15% dividend yield ever be sustainable?
BY JOHN KINGHAM dividend hunter Can a 15% dividend yield ever be sustainable? Very few stocks ever have a dividend yield of 15% or more, and if they do then the dividend has probably already been cut or
More informationPharmacy Stakeholder Meeting December 20, 2016
Pharmacy Stakeholder Meeting December 20, 2016 WELCOME & AGENDA 9:30 Introductions (TennCare) 9:40 Tennessee AAC Survey (Myers and Stauffer LC) CMS Covered Outpatient Drugs Final Rule (CMS-2345-FC) Actual
More informationCARDINAL HEALTH REPORTS SECOND QUARTER RESULTS, REVISES EPS OUTLOOK
7000 Cardinal Place Dublin,OH 43017 www.cardinalhealth.com Contacts: Media: Jim Mazzola (614) 757-3690 jim.mazzola@cardinalhealth.com FOR IMMEDIATE RELEASE Investors: Bob Reflogal (614) 757-7542 bob.reflogal@cardinalhealth.com
More informationUnderstanding Defined Benefit Plans
Thorley Wealth Management, Inc. Elizabeth Thorley, MS, CFP, CLU, AIF, AEP CEO & President 1478 Marsh Road Pittsford, NY 14534 585-512-8453 x205 Fax: 585.625.0477 ethorley@thorleywm.com www.thorleywm.com
More informationProtecting the Health of New Brunswickers
Pharmasave Drugs Atlantic Ltd. is pleased to provide this submission as part of the consultation process for the New Brunswick government s Fair Drug Prices for New Brunswickers. The New Brunswick government
More informationA distinctive local company with national standards. Practical Credit Control & New [GDPR] Data Protection Regulations
A distinctive local company with national standards Practical Credit Control & New [GDPR] Data Protection Regulations 1 Introduction DSL started collecting veterinary debt 11 years ago and now help over
More informationTake the lead on user experience, speed to market and upselling.
Take the lead on user experience, speed to market and upselling. Enhance user experience in all distribution channels, from traditional face-to-face to direct online distribution. Available disconnected
More informationTHE OHIO DEPARTMENT OF MEDICAID
HEALTH WEALTH CAREER THE OHIO DEPARTMENT OF MEDICAID PHARMACY STAKEHOLDER ENGAGEMENT MEETING September 13, 2016 Presenter Scott Banken, Mercer WHY WHO HOW The ODM is conducting a Professional Dispensing
More informationHealth Benefit Directions
An MBGH Employer Benchmarking Survey 2017-2018 Health Benefit Directions November 2016 Copyright (c) 2016 MBGH 1 Survey Overview Survey was sent to all employer members of business coalitions Responses
More informationNCPA Summary of CMS Medicaid Covered Outpatient Drugs AMP Final Rule Prepared January NCPA Advocacy at Work
NCPA Summary of CMS Medicaid Covered Outpatient Drugs AMP Final Rule Prepared January 2016 The Centers for Medicare & Medicaid Services (CMS) recently issued a 658-page, oftendelayed, final rule on the
More informationHow Do You Calculate Cash Flow in Real Life for a Real Company?
How Do You Calculate Cash Flow in Real Life for a Real Company? Hello and welcome to our second lesson in our free tutorial series on how to calculate free cash flow and create a DCF analysis for Jazz
More informationFOOD SAFETY RISK ANALYSIS
Appendix D FOOD SAFETY RISK ANALYSIS 1.0 RISK IN FOOD PROCESSING 1.1 Risk Analysis 1.2 Risk Assessment 1.3 When to do a Risk Assessment 1.4 Risk Assessment and HACCP 1.5 The Health Risk Assessment Model
More informationMedical Benefits Trust
UAW RETIREE Medical Benefits Trust Dear UAW Trust Member, HEALTH CARE BENEFIT HIGHLIGHTS 2018 At the UAW Retiree Medical Benefits Trust (the Trust ), we recognize how important health care benefits are
More informationHealth Reform Hits Main Street
Health Reform Hits Main Street The YouToons explain the new health law. Written and produced by the Kaiser Family Foundation Let s face it folks, the new health care reform law is com-plex. It runs about
More informationHEALTH AND SAFETY CODE SECTION
HEALTH AND SAFETY CODE SECTION 25251-25257.1 25251. For purposes of this article, the following definitions shall apply: (a) "Clearinghouse" means the Toxics Information Clearinghouse established pursuant
More informationFOR IMMEDIATE RELEASE 19 March 2010 A&D PHARMA HOLDINGS N.V. UNAUDITED FINANCIAL STATEMENTS FOR THE 12 MONTHS ENDED 31 DECEMBER 2009
FOR IMMEDIATE RELEASE 19 March 2010 A&D PHARMA HOLDINGS N.V. UNAUDITED FINANCIAL STATEMENTS FOR THE 12 MONTHS ENDED 31 DECEMBER 2009 18% year-on-year RON denominated consolidated sales growth 3% year-on-year
More informationWaters Corporation Management Presentation
Waters Corporation Management Presentation Chris O Connell Chairman & Chief Executive Officer January 2019 Cautionary Statements This presentation may contain forward-looking statements regarding future
More informationSustainability Accounting Standards. Health care sector: health care distributors
Sustainability Accounting Standards Health care sector: health care distributors What you need to know about the Health Care Standards for the health care distribution industry by the Sustainability Accounting
More information2015 Situation Report on Counterfeiting in the European Union
2015 Situation Report on Counterfeiting in the European Union April 2015 Foreword Intellectual Property Rights (IPR) help ensure that innovators and creators get a fair return for their work, encourage
More informationPublic Consultation on reduced VAT rates for electronically supplied publications
Case Id: 024c67de-d37f-44d9-91cb-7d545aedaecf Date: 19/09/2016 13:55:21 Public Consultation on reduced VAT rates for electronically supplied publications Fields marked with are mandatory. 1 Objective of
More informationFormulary Services EULA
Formulary Services EULA Formulary Services. Allscripts is reliant on Surescripts in facilitating the provision of the Formulary Services described in Schedule A (the Formulary Services Terms ). If Surescripts
More informationMORTGAGEBOT END-TO-END LENDING TECHNOLOGY
MORTGAGEBOT END-TO-END LENDING TECHNOLOGY 2 FINASTRA Brochure INTRODUCTION Mortgagebot Solutions to Move Your Lending Forward The Mortgagebot platform automatically address compliance issues, while delivering
More informationSINGLE MARKET - FIFTH BARRIER DIFFERING SOCIAL, ENVIRONMENTAL & OTHER STANDARDS. environmental rules (like pollution standards) or consumer
SINGLE MARKET - FIFTH BARRIER DIFFERING SOCIAL, ENVIRONMENTAL & OTHER STANDARDS But harmonisation goes beyond product standards. If countries had significantly different social protection rules (like pay),
More informationPAI Secure Program Guide
PAI Secure Program Guide A complete guide to understanding the Payment Card Industry Data Security Requirements (PCI DSS) and utilizing the PAI Secure Program Welcome to PAI Secure, a unique 4-step PCI-DSS
More informationNATIONAL COUNCIL OF INSURANCE LEGISLATORS (NCOIL) Workers Compensation Pharmaceutical Reimbursement Rates Model Act
NATIONAL COUNCIL OF INSURANCE LEGISLATORS (NCOIL) Workers Compensation Pharmaceutical Reimbursement Rates Model Act Drafting Note: This model language is intended for inclusion in state insurance codes
More informationUnderstanding Defined Benefit Plans
Select Portfolio Management, Inc 26800 Aliso Viejo Parkway Suite 150 Aliso Viejo, CA 92656 949-975-7900 800-445-9822 info@selectportfolio.com www.selectportfolio.com Understanding Defined Benefit Plans
More informationDealer Application Package
Dealer Application Package Dear Valued Dealer: Welcome to the TXR family and we thank you in advance for your support and promotion of the TXR portfolio of products. To allow us to meet the requirements
More informationIB Interview Guide: Case Study Exercises Three-Statement Modeling Case (30 Minutes)
IB Interview Guide: Case Study Exercises Three-Statement Modeling Case (30 Minutes) Hello, and welcome to our first sample case study. This is a three-statement modeling case study and we're using this
More informationIGNITING GROWTH. Strategies for Life Sciences Companies to Stay Ahead of Changing Revenue Recognition Guidelines
IGNITING GROWTH Strategies for Life Sciences Companies to Stay Ahead of Changing Revenue Recognition Guidelines What the New Guidelines Mean for Life Sciences Companies 04 Overview 05 Why the Urgency?
More informationSHPA Response to Consultation on the Community Service Obligation (CSO) Funding Pool Obligations (2018)
SHPA Response to Consultation on the Community Service Obligation (CSO) Funding Pool Obligations (2018) The Society of Hospital Pharmacists of Australia (SHPA) is the national professional organisation
More information3 Price Action Signals to Compliment ANY Approach to ANY Market
3 Price Action Signals to Compliment ANY Approach to ANY Market Introduction: It is important to start this report by being clear that these signals and tactics for using Price Action are meant to compliment
More information12 Best Practices for Better Budgeting
12 Best Practices for Better Budgeting John Herbstritt Chief Solutions Architect Cathy Fregelette Financial Practice Director Executive Summary Let s face it: budgeting is often a painful process. Even
More informationNSBA 2017 SMALL BUSINESS TAXATION SURVEY NSBA 2018 SMALL BUSINESS TAXATION SURVEY
NSBA 2017 SMALL BUSINESS TAXATION SURVEY NSBA 2018 SMALL BUSINESS TAXATION SURVEY FOREWORD At the end of 2017, Congress passed--and the President signed--legislation to reform federal taxes, the Tax Cuts
More informationAccounting Qualification. Indirect Tax (Level 3) Reference material
Accounting Qualification Indirect Tax (Level 3) Reference material The Association of Accounting Technicians December 2010 Reference material for AAT assessment of Indirect Tax Introduction This document
More informationCWAG Prescription Drug Pricing Webinar
CWAG Prescription Drug Pricing Webinar January 9, 2018 Kipp Snider, J.D. Vice President, State Policy Pharmaceutical Research & Manufacturers of America (PhRMA) Medicines Are Expected to Account for a
More informationKroll Ontrack, LLC Prescription Drug Plan. Plan Document and Summary Plan Description
Kroll Ontrack, LLC Prescription Drug Plan Plan Document and Summary Plan Description Effective December 9, 2016 Kroll Ontrack, LLC reserves the right to amend the Kroll Ontrack, LLC Health & Welfare Plan
More informationTrading shares with CFDs allows Traders to gain full exposure with a small initial investment. David Berg - Financial Analyst
Trading shares with CFDs allows Traders to gain full exposure with a small initial investment David Berg - Financial Analyst Introduction to Stock Trading When an investor purchases a share of stock, they're
More informationCHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT
CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT 58-29E-1. Definition of terms. Terms used in this chapter mean: (1) "Covered entity," a nonprofit hospital or medical service corporation, health insurer, health
More informationA SEISMIC SHIFT HOW THE DOL S FIDUCIARY RULES WILL UPEND FINANCIAL ADVICE AND WHAT ADVISORS SHOULD BE DOING RIGHT NOW TO PREPARE SPONSORED BY
A SEISMIC SHIFT HOW THE DOL S FIDUCIARY RULES WILL UPEND FINANCIAL ADVICE AND WHAT ADVISORS SHOULD BE DOING RIGHT NOW TO PREPARE SPONSORED BY O n October 7, Merrill Lynch announced the end of commissionbased
More informationINTERNATIONAL TAX SOLUTIONS OVERVIEW
THOMSON REUTERS ONESOURCE INTERNATIONAL TAX S OVERVIEW PILLARS OF INTERNATIONAL TAX EFFECTIVENESS INTERNATIONAL TAX RESEARCH CHECKPOINT WORLD RESEARCH Checkpoint World Orbitax PROCESS WorkFlow Manager
More informationWorld Trademark Review. Brinks Hofer Gilson & Lione. Pharmaceutical Trademarks 2013/2014. A Global Guide. Fourth Edition
World Trademark Review Pharmaceutical Trademarks 2013/2014 A Global Guide Fourth Edition United States Contributing firm Authors Nicholas de la Torre and Jennifer Theis Selection, clearance and registration
More informationSecond Phase of Alberta Pharmaceutical Strategy announced
W I N T E R 2 0 1 0 Second Phase of Alberta Pharmaceutical Strategy announced In late October 2009, the Government of Alberta announced Phase Two of the Alberta Pharmaceutical Strategy, a plan to make
More informationScenic Video Transcript Dividends, Closing Entries, and Record-Keeping and Reporting Map Topics. Entries: o Dividends entries- Declaring and paying
Income Statements» What s Behind?» Statements of Changes in Owners Equity» Scenic Video www.navigatingaccounting.com/video/scenic-dividends-closing-entries-and-record-keeping-and-reporting-map Scenic Video
More informationSTERILISATION AND THE MDR
STERILISATION AND THE MDR SVN, Ede 17 March 2017 Erik Vollebregt www.axonadvocaten.nl Agenda Sterilisation specifics Amended definition of MD SUD reprocessing Some of the legal related obligations: New
More informationRevenue Recognition for Life Sciences Companies
Revenue Recognition for Life Sciences Companies IGNITING GROWTH WHAT THE NEW GUIDELINES MEAN FOR LIFE SCIENCES COMPANIES In 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards
More informationFinal Report Draft regulatory technical standards on indirect clearing arrangements under EMIR and MiFIR
Final Report Draft regulatory technical standards on indirect clearing arrangements under EMIR and MiFIR 26 May 2016 ESMA/2016/725 Table of Contents 1 Executive Summary... 3 2 Indirect clearing arrangements...
More informationSustainability Accounting Standards Board
Sustainability Accounting Standards Board Moving toward a market standard for the disclosure of material sustainability information Eric Kane, Health Care Analyst September 20, 2017 2017 SASB Agenda Introduction
More informationBELGIUM LUXEMBOURG Loading specifications for MAH data Version 2-11/5/2018
BELGIUM LUXEMBOURG Loading specifications for MAH data Version 2-11/5/2018 1. Purpose The purpose of this document is to provide additional information regarding the product data that have to be loaded
More informationThe Patient Protection and Affordable Care Act of Enacted March, 2010
The Patient Protection and Affordable Care Act of 2010 An Overview of the New Health Care Law Enacted March, 2010 1 The Patient Protection and Affordable Care Act of 2010 March, 2010: President Obama Signed
More informationHENRY SCHEIN INC FORM 10-K. (Annual Report) Filed 02/11/15 for the Period Ending 12/27/14
HENRY SCHEIN INC FORM 10-K (Annual Report) Filed 02/11/15 for the Period Ending 12/27/14 Address 135 DURYEA RD MELVILLE, NY, 11747 Telephone 6318435500 CIK 0001000228 Symbol HSIC SIC Code 5047 - Wholesale-Medical,
More informationState of Florida Department of Business and Professional Regulation Division of Drugs, Devices and Cosmetics
State of Florida Department of Business and Professional Regulation Division of Drugs, Devices and Cosmetics Application for Veterinary Prescription Drug Wholesale Distributor Permit Form.: DBPR-DDC-216
More informationINSIDE DAYS. The One Trading Secret That Could Make You Rich
The One Trading Secret That Could Make You Rich INSIDE DAYS What 'Inside Days' Are, How To Identify Them, The Setup, How They Work, Entrance Criteria, Management and Exit Criteria for MAXIMUM PROFITS IMPORTANT
More informationTABLE OF CONTENTS. Annexes: I. Notification form II. Methodological framework for facilitating consistent risk estimation and evaluation
ANNEX GUIDELINES FOR THE NOTIFICATION OF DANGEROUS CONSUMER PRODUCTS TO THE COMPETENT AUTHORITIES OF THE MEMBER STATES BY PRODUCERS AND DISTRIBUTORS IN ACCORDANCE WITH ARTICLE 5(3) OF DIRECTIVE 2001/95/EC
More informationHIPAA 5010 Webinar Questions and Answer Session
HIPAA 5010 Webinar Questions and Answer Session Q: After Jan 2012, do the providers who bill on paper have to worry about 5010? Q: What if a provider submits all claims via paper? Do the new 5010 guidelines
More informationSmarter, Faster Product Innovation. Strategic Imperatives for Property & Casualty Insurers
Smarter, Faster Product Innovation Strategic Imperatives for Property & Casualty Insurers Insurers no longer have the luxury of long lead times and slow, cautious product rollouts. The insurance industry
More informationPlunging into PBM Pricing Spread to Create Client Centric Contracts
Plunging into PBM Pricing Spread to Create Client Centric Contracts Scott Haas, Vice President Integrated Healthcare Metrics SIIA 32 nd Annual National Educational Conference & Expo October 2, 2012 Wells
More informationLawyer Chief Expert at the Ministry of Health
by Jakub Adamski Vienna, 30/09/2011 Lawyer Chief Expert at the Ministry of Health participation in European Commission and Council working groups member of the EUCERD coordination of works of the Rare
More informationAmstar Brands Payment Methods Manual. First Data Locations
Amstar Brands Payment Methods Manual First Data Locations Table of Contents Introduction... 3 Valid Card Types... 3 Authorization Numbers, Merchant ID Numbers and Request for Copy Fax Numbers... 4 Other
More informationTop Things To Know KOFA HIGH SCHOOL SOCIAL SCIENCES DEPARTMENT ECONOMICS - PERSONAL FINANCE WORKSHOPS # 4 - CONTROLLING DEBT
KOFA HIGH SCHOOL SOCIAL SCIENCES DEPARTMENT ECONOMICS - PERSONAL FINANCE WORKSHOPS # 4 - CONTROLLING DEBT Vocabulary Keys : Words that are in bold = are terms that appear in one of the chapters, Words
More informationA Better Way to Navigate the Complex World of Pharmacy Benefits. Pharmacy Purchasing Coalition
A Better Way to Navigate the Complex World of Pharmacy Benefits 1 Pharmacy Purchasing Coalition Shared BOCES service designed to help self-insured school districts and municipalities manage prescription
More informationEFTA Surveillance Authority GUIDELINES
EFTA Surveillance Authority GUIDELINES for the management of the Rapid Information System RAPEX established under Article 12 and of the notification procedure established under Article 11 of Directive
More informationFile Number S ; Custody of Funds or Securities of Clients by Investment Advisers
Via Electronic Mail: rule-comments@sec.gov Elizabeth M. Murphy Secretary U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-1090 Re: File Number S7-09-09; Custody of Funds or
More informationThe Blockchain Game Changer
The Blockchain Game Changer IOD Boardroom Magazine 27 April 2018 You may not fully understand what blockchain is yet but within the next few years it could underpin the way you do business. Although blockchain
More information